|
Transplantation
Citations 191-200 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Stem-cell ecology and stem cells in motion
- Thalia Papayannopoulou and David T. Scadden
Blood 2008; 111: 3923-3930.
[Abstract]
[Full text]
[PDF]
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage
- Marco Ladetto, Federica De Marco, Fabio Benedetti, Umberto Vitolo, Caterina Patti, Alessandro Rambaldi, Alessandro Pulsoni, Maurizio Musso, Anna M. Liberati, Attilio Olivieri, Andrea Gallamini, Enrico Pogliani, Delia Rota Scalabrini, Vincenzo Callea, Francesco Di Raimondo, Vincenzo Pavone, Alessandra Tucci, Sergio Cortelazzo, Alessandro Levis, Mario Boccadoro, Ignazio Majolino, Alessandro Pileri, Alessandro M. Gianni, Roberto Passera, Paolo Corradini, and Corrado Tarella, for Gruppo Italiano Trapianto di Midollo Osseo (GITMO), Intergruppo Italiano Linfomi (IIL)
Blood 2008; 111: 4004-4013.
[Abstract]
[Full text]
[PDF]
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)
- John A. Thompson, Richard I. Fisher, Michael LeBlanc, Stephen J. Forman, Oliver W. Press, Joseph M. Unger, Auayporn P. Nademanee, Patrick J. Stiff, Stephen H. Petersdorf, and Alexander Fefer
Blood 2008; 111: 4048-4054.
[Abstract]
[Full text]
[PDF]
Donor cell–derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation
- Massimo Dominici, Roberta Marino, Valeria Rasini, Carlotta Spano, Paolo Paolucci, Pierfranco Conte, Ted J. Hofmann, and Edwin M. Horwitz
Blood 2008; 111: 4386-4391.
[Abstract]
[Full text]
[PDF]
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique
- Stephan Mielke, Raquel Nunes, Katayoun Rezvani, Vicki S. Fellowes, Annie Venne, Scott R. Solomon, Yong Fan, Emma Gostick, David A. Price, Christian Scotto, Elizabeth J. Read, and A. John Barrett
Blood 2008; 111: 4392-4402.
[Abstract]
[Full text]
[PDF]
CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease
- Tsukasa Hori, Yasuyoshi Naishiro, Hitoshi Sohma, Nobuhiro Suzuki, Naoki Hatakeyama, Masaki Yamamoto, Tomoko Sonoda, Yuka Mizue, Kohzoh Imai, Hiroyuki Tsutsumi, and Yasuo Kokai
Blood 2008; 111: 4403-4412.
[Abstract]
[Full text]
[PDF]
Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab
- Halvard Bonig, Annette Wundes, Kai-Hsin Chang, Sylvia Lucas, and Thalia Papayannopoulou
Blood 2008; 111: 3439-3441.
[Abstract]
[Full text]
[PDF]
The TNF (–308A) polymorphism is associated with microchimerism in transfused trauma patients
- Ryan M. Gill, Tzong-Hae Lee, Garth H. Utter, William F. Reed, Li Wen, Dan Chafets, and Michael P. Busch
Blood 2008; 111: 3880-3883.
[Abstract]
[Full text]
[PDF]
CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL
- Catherine Matte-Martone, Jinli Liu, Dhanpat Jain, Jennifer McNiff, and Warren D. Shlomchik
Blood 2008; 111: 3884-3892.
[Abstract]
[Full text]
[PDF]
The monoclonal anti–VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans
- Fabian Zohren, Diamandis Toutzaris, Viola Klärner, Hans-Peter Hartung, Bernd Kieseier, and Rainer Haas
Blood 2008; 111: 3893-3895.
[Abstract]
[Full text]
[PDF]
|
|
